Skip to content

The Effects of Angle Kappa on Clinical Outcomes With the PanOptix Intraocular Lens

Evaluation of Angle Kappa and Different Intraocular Lens Calculation Formulas in Acrysof® IQ Panoptix Intraocular Lens Outcomes, Visual Disturbances and Patient Satisfaction

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04242875
Enrollment
30
Registered
2020-01-27
Start date
2020-01-21
Completion date
2021-04-27
Last updated
2023-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pseudophakia

Brief summary

Angle Kappa is considered a potential factor in explaining suboptimal outcomes with intraocular lenses (IOLs), particularly multifocal IOLs. Some evidence suggests this is not the case. This study was designed to investigate correlations between angle kappa and post-surgical outcomes with a trifocal IOL.

Detailed description

The main complaint of patients who received a presbyopia correcting lens (regardless of the design) are visual disturbances such as glare, halos (rings around lights), starbursts (rays around light sources), mainly at night. The degree of limitation or how bothered patients are varies from patient to patient. To explain these symptoms different theories have been proposed including splitting the light into different focal points which decreases the intensity of the light reaching the retina. Most factors are common to all patients who received the lens; however, patients are not equally affected by these symptoms. Angle kappa has been considered a factor. Angle κ is the angle between the visual axis (straight line that passes through both the center of the pupil and the center of the fovea) and the pupillary axis (perpendicular line to the surface of the cornea that passes through the center of the pupil).

Interventions

DIAGNOSTIC_TESTAngle Kappa

Angle kappa will be measured using the OPD III scan.

OTHERVisual disturbance questionnaire.

Questionnaire evaluating visual disturbances.

Sponsors

Science in Vision
CollaboratorOTHER
Carolina Eyecare Physicians, LLC
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum

Inclusion criteria

1. Subject is undergoing bilateral lens extraction with intraocular lens implantation (PanOptix lens). 2. Willing and able to provide written informed consent for participation in the study 3. Willing and able to comply with scheduled visits and other study procedures. 4. Scheduled to undergo standard cataract surgery with topical anesthesia in both eyes within 6 to 30 days between surgeries. 5. Subjects who require an IOL power in the range of +6.0 D to +30.0 D only. 6. Subjects who require a TFNT00 or TFNT30 to TFNT60 IOL. 7. Potential postoperative visual acuity of 0.2 logMAR (20/32 Snellen) or better in both eyes.

Exclusion criteria

1. Severe preoperative ocular pathology 2. Subjects who require a higher toric power than the one available (TFNT60). 3. Uncontrolled diabetes. 4. Use of any systemic or topical drug known to interfere with visual performance. 5. Contact lens use during the active treatment portion of the trial. 6. Any concurrent infectious/non-infectious conjunctivitis, keratitis or uveitis. 7. Clinically significant corneal dystrophy 8. History of chronic intraocular inflammation. 9. History of retinal detachment. 10. Pseudoexfoliation syndrome or any other condition that has the potential to weaken the zonules. 11. Previous ocular surgery. 12. Severe dry eye 13. Pupil abnormalities 14. Anesthesia other than topical anesthesia (i.e. retrobulbar, general, etc). 15. Any clinically significant, serious or severe medical or psychiatric condition that may increase the risk associated with study participation or may interfere with the interpretation of study results. 16. Participation in (or current participation) any ophthalmic investigational drug or ophthalmic device trial within the previous 30 days prior to the start date of this trial.

Design outcomes

Primary

MeasureTime frameDescription
Effect of Angle Kappa in Visual Disturbances3 monthsFrequency of visual disturbances with magnitude of Angle Kappa

Secondary

MeasureTime frameDescription
Satisfaction With Vision by Magnitude of Angle Kappa3 monthsOverall satisfaction score after surgery, categorized by magnitude of angle kappa

Countries

United States

Participant flow

Participants by arm

ArmCount
PanOptix
Participants will receive the PanOptix intraocular lens. Angle Kappa: Angle kappa will be measured using the OPD III scan. Visual disturbance questionnaire.: Questionnaire evaluating visual disturbances.
30
PanOptix
Participants will receive the PanOptix intraocular lens. Angle Kappa: Angle kappa will be measured using the OPD III scan. Visual disturbance questionnaire.: Questionnaire evaluating visual disturbances.
60
Total90

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyAdverse Event2

Baseline characteristics

CharacteristicPanOptix
Age, Continuous68.4 years
STANDARD_DEVIATION 8.1
Angle Kappa0.29 mm
STANDARD_DEVIATION 0.17
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
30 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
30 Participants
Region of Enrollment
United States
30 participants
Sex: Female, Male
Female
23 Participants
Sex: Female, Male
Male
7 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 30
other
Total, other adverse events
0 / 30
serious
Total, serious adverse events
0 / 30

Outcome results

Primary

Effect of Angle Kappa in Visual Disturbances

Frequency of visual disturbances with magnitude of Angle Kappa

Time frame: 3 months

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
AK < 0.3 mmEffect of Angle Kappa in Visual DisturbancesHalos frequencyNever3 Participants
AK < 0.3 mmEffect of Angle Kappa in Visual DisturbancesStarburst frequencyMost of the time2 Participants
AK < 0.3 mmEffect of Angle Kappa in Visual DisturbancesStarburst frequencyNever1 Participants
AK < 0.3 mmEffect of Angle Kappa in Visual DisturbancesHalos frequencyRarely0 Participants
AK < 0.3 mmEffect of Angle Kappa in Visual DisturbancesGlare frequencySometimes3 Participants
AK < 0.3 mmEffect of Angle Kappa in Visual DisturbancesHalos frequencyAlways3 Participants
AK < 0.3 mmEffect of Angle Kappa in Visual DisturbancesHalos frequencySometimes3 Participants
AK < 0.3 mmEffect of Angle Kappa in Visual DisturbancesStarburst frequencyAlways4 Participants
AK < 0.3 mmEffect of Angle Kappa in Visual DisturbancesHalos frequencyMost of the time1 Participants
AK < 0.3 mmEffect of Angle Kappa in Visual DisturbancesStarburst frequencySometimes3 Participants
AK < 0.3 mmEffect of Angle Kappa in Visual DisturbancesGlare frequencyMost of the time0 Participants
AK < 0.3 mmEffect of Angle Kappa in Visual DisturbancesGlare frequencyRarely1 Participants
AK < 0.3 mmEffect of Angle Kappa in Visual DisturbancesGlare frequencyAlways2 Participants
AK < 0.3 mmEffect of Angle Kappa in Visual DisturbancesGlare frequencyNever4 Participants
AK < 0.3 mmEffect of Angle Kappa in Visual DisturbancesStarburst frequencyRarely0 Participants
AK > 0.3 and <= 0.4 mmEffect of Angle Kappa in Visual DisturbancesStarburst frequencyRarely0 Participants
AK > 0.3 and <= 0.4 mmEffect of Angle Kappa in Visual DisturbancesGlare frequencyNever4 Participants
AK > 0.3 and <= 0.4 mmEffect of Angle Kappa in Visual DisturbancesGlare frequencyRarely0 Participants
AK > 0.3 and <= 0.4 mmEffect of Angle Kappa in Visual DisturbancesGlare frequencySometimes2 Participants
AK > 0.3 and <= 0.4 mmEffect of Angle Kappa in Visual DisturbancesGlare frequencyMost of the time0 Participants
AK > 0.3 and <= 0.4 mmEffect of Angle Kappa in Visual DisturbancesGlare frequencyAlways0 Participants
AK > 0.3 and <= 0.4 mmEffect of Angle Kappa in Visual DisturbancesHalos frequencyNever4 Participants
AK > 0.3 and <= 0.4 mmEffect of Angle Kappa in Visual DisturbancesHalos frequencyRarely0 Participants
AK > 0.3 and <= 0.4 mmEffect of Angle Kappa in Visual DisturbancesHalos frequencySometimes2 Participants
AK > 0.3 and <= 0.4 mmEffect of Angle Kappa in Visual DisturbancesHalos frequencyMost of the time0 Participants
AK > 0.3 and <= 0.4 mmEffect of Angle Kappa in Visual DisturbancesHalos frequencyAlways0 Participants
AK > 0.3 and <= 0.4 mmEffect of Angle Kappa in Visual DisturbancesStarburst frequencyNever3 Participants
AK > 0.3 and <= 0.4 mmEffect of Angle Kappa in Visual DisturbancesStarburst frequencySometimes3 Participants
AK > 0.3 and <= 0.4 mmEffect of Angle Kappa in Visual DisturbancesStarburst frequencyMost of the time0 Participants
AK > 0.3 and <= 0.4 mmEffect of Angle Kappa in Visual DisturbancesStarburst frequencyAlways0 Participants
AK > 0.4 mmEffect of Angle Kappa in Visual DisturbancesHalos frequencyNever3 Participants
AK > 0.4 mmEffect of Angle Kappa in Visual DisturbancesStarburst frequencyMost of the time1 Participants
AK > 0.4 mmEffect of Angle Kappa in Visual DisturbancesStarburst frequencyNever6 Participants
AK > 0.4 mmEffect of Angle Kappa in Visual DisturbancesGlare frequencyAlways0 Participants
AK > 0.4 mmEffect of Angle Kappa in Visual DisturbancesGlare frequencyMost of the time2 Participants
AK > 0.4 mmEffect of Angle Kappa in Visual DisturbancesStarburst frequencyRarely0 Participants
AK > 0.4 mmEffect of Angle Kappa in Visual DisturbancesGlare frequencySometimes5 Participants
AK > 0.4 mmEffect of Angle Kappa in Visual DisturbancesGlare frequencyNever5 Participants
AK > 0.4 mmEffect of Angle Kappa in Visual DisturbancesStarburst frequencySometimes5 Participants
AK > 0.4 mmEffect of Angle Kappa in Visual DisturbancesHalos frequencySometimes5 Participants
AK > 0.4 mmEffect of Angle Kappa in Visual DisturbancesGlare frequencyRarely0 Participants
AK > 0.4 mmEffect of Angle Kappa in Visual DisturbancesHalos frequencyMost of the time2 Participants
AK > 0.4 mmEffect of Angle Kappa in Visual DisturbancesHalos frequencyRarely1 Participants
AK > 0.4 mmEffect of Angle Kappa in Visual DisturbancesStarburst frequencyAlways0 Participants
AK > 0.4 mmEffect of Angle Kappa in Visual DisturbancesHalos frequencyAlways1 Participants
Secondary

Satisfaction With Vision by Magnitude of Angle Kappa

Overall satisfaction score after surgery, categorized by magnitude of angle kappa

Time frame: 3 months

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
AK < 0.3 mmSatisfaction With Vision by Magnitude of Angle KappaSatisfied3 Participants
AK < 0.3 mmSatisfaction With Vision by Magnitude of Angle KappaNeither satisfied nor dissatisfied1 Participants
AK < 0.3 mmSatisfaction With Vision by Magnitude of Angle KappaVery dissatisfied0 Participants
AK < 0.3 mmSatisfaction With Vision by Magnitude of Angle KappaDissatisfied0 Participants
AK < 0.3 mmSatisfaction With Vision by Magnitude of Angle KappaVery satisfied6 Participants
AK > 0.3 and <= 0.4 mmSatisfaction With Vision by Magnitude of Angle KappaNeither satisfied nor dissatisfied0 Participants
AK > 0.3 and <= 0.4 mmSatisfaction With Vision by Magnitude of Angle KappaVery dissatisfied1 Participants
AK > 0.3 and <= 0.4 mmSatisfaction With Vision by Magnitude of Angle KappaDissatisfied0 Participants
AK > 0.3 and <= 0.4 mmSatisfaction With Vision by Magnitude of Angle KappaSatisfied1 Participants
AK > 0.3 and <= 0.4 mmSatisfaction With Vision by Magnitude of Angle KappaVery satisfied4 Participants
AK > 0.4 mmSatisfaction With Vision by Magnitude of Angle KappaVery satisfied9 Participants
AK > 0.4 mmSatisfaction With Vision by Magnitude of Angle KappaSatisfied2 Participants
AK > 0.4 mmSatisfaction With Vision by Magnitude of Angle KappaVery dissatisfied0 Participants
AK > 0.4 mmSatisfaction With Vision by Magnitude of Angle KappaNeither satisfied nor dissatisfied1 Participants
AK > 0.4 mmSatisfaction With Vision by Magnitude of Angle KappaDissatisfied0 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026